| 000 | 01059 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518032034.0 | ||
| 264 | 0 | _c20200601 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2019.03.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeibowitz-Amit, Raya | |
| 245 | 0 | 0 |
_aReply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53. _h[electronic resource] |
| 260 |
_bEuropean urology _c07 2019 |
||
| 300 |
_ae19 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProstatic Neoplasms |
| 650 | 0 | 4 | _aProstatic Neoplasms, Castration-Resistant |
| 650 | 0 | 4 | _aRadium |
| 773 | 0 |
_tEuropean urology _gvol. 76 _gno. 1 _gp. e19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2019.03.013 _zAvailable from publisher's website |
| 999 |
_c29533047 _d29533047 |
||